Cantargia: New Investigator-Sponsored Trial in Large Indication - Redeye

Redeye comments on the new investigator-sponsored phase II study in up to 59 current or previous smokers with multifocal high-risk lung nodules, and therefore at risk of developing lung cancer. This is a large market opportunity.

Länk till analysen i sin helhet: https://www.redeye.se/research/1171666/cantargia-new-investigator-sponsored-trial-in-large-indication?utm_source=finwire&utm_medium=RSS